We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase 1b/2 Study of OMP-59R5 in Combination With Etoposide and Platinum Therapy in Subjects With Untreated Extensive Stage Small Cell Lung Cancer (PINNACLE) (PINNACLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01859741
Recruitment Status : Active, not recruiting
First Posted : May 22, 2013
Last Update Posted : January 24, 2018
Information provided by (Responsible Party):
OncoMed Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : May 2017
  Estimated Study Completion Date : February 2018